Australia markets closed

Teladoc Health, Inc. (TDOC)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
8.64-0.40 (-4.42%)
At close: 04:00PM EDT
8.60 -0.04 (-0.46%)
After hours: 08:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.48B
Enterprise value 1.91B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.55
Price/book (mrq)0.98
Enterprise value/revenue 0.73
Enterprise value/EBITDA 12.16

Trading information

Stock price history

Beta (5Y monthly) 0.91
52-week change 3-53.57%
S&P500 52-week change 330.69%
52-week high 322.54
52-week low 36.76
50-day moving average 37.94
200-day moving average 313.06

Share statistics

Avg vol (3-month) 36.27M
Avg vol (10-day) 34.54M
Shares outstanding 5171.22M
Implied shares outstanding 6179.14M
Float 8161.02M
% held by insiders 10.82%
% held by institutions 183.81%
Shares short (13 Sept 2024) 427M
Short ratio (13 Sept 2024) 45.15
Short % of float (13 Sept 2024) 420.49%
Short % of shares outstanding (13 Sept 2024) 415.77%
Shares short (prior month 15 Aug 2024) 429.21M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 June 2024

Profitability

Profit margin -38.54%
Operating margin (ttm)-7.66%

Management effectiveness

Return on assets (ttm)-3.42%
Return on equity (ttm)-52.96%

Income statement

Revenue (ttm)2.61B
Revenue per share (ttm)15.60
Quarterly revenue growth (yoy)-1.50%
Gross profit (ttm)N/A
EBITDA 65.96M
Net income avi to common (ttm)-1.01B
Diluted EPS (ttm)-5.96
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.16B
Total cash per share (mrq)6.79
Total debt (mrq)1.59B
Total debt/equity (mrq)105.78%
Current ratio (mrq)1.66
Book value per share (mrq)8.78

Cash flow statement

Operating cash flow (ttm)333.29M
Levered free cash flow (ttm)274.05M